Call us 24/7

CTCA Lung Cancer Center, Tulsa

Your treatment options

Lung Cancer Center

Because lung cancer is often not detected until it has reached an advanced stage, time is an important factor in its treatment. At the Lung Cancer Center at Cancer Treatment Centers of America® (CTCA) in Tulsa, the many aspects of your care—from diagnostics and consultations to treatments and follow-up visits—are coordinated and delivered under one roof, so you don’t have to worry about driving from location to location, and so you can start your personalized treatment plan as quickly as possible.

Our team of lung cancer specialists, led by Interventional Pulmonologist Daniel Nader, DO, FCCP, FACP, works together to deliver a treatment plan tailored to your needs. Each patient’s plan is individualized and based on new and emerging technologies, including genomic-based cancer care, immunotherapy, stereotactic body radiotherapy, brachytherapy and photodynamic therapy, and supplemented with evidence-informed supportive therapies to manage side effects.

The comprehensive care model at CTCA® is designed to educate you on the options available to treat your specific lung cancer type and stage, so you can make informed decisions about your care.

CTCA Tulsa has earned The Joint Commission's Gold Seal of Approval® for Lung Cancer Certification. The Joint Commission's Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses certain core areas.

Learn more about what it means to earn a Gold Seal of Approval® for Lung Cancer Certification


Meet some of our Lung Cancer Center doctors

Peter Baik - Lung Cancer Institute Leader, Cancer Treatment Centers of America

Peter Baik

Thoracic Surgery Director, CTCA Lung Cancer Institute

Kendal Hervert - Pulmonologist

Kendal Hervert

Pulmonologist, CTCA Tulsa

Douglas Kelly - Radiation Oncologist

Douglas Kelly

Radiation Oncologist, CTCA Tulsa

Daniel Nader - Chief, CTCA Division of Pulmonary Services, Department of Medicine

Daniel Nader

Chief of Staff, CTCA Tulsa

Theodore Pollock - Director of Medical Oncology & Medical Staff Secretary

Theodore Pollock

Director of Medical Oncology & Medical Staff Secretary, CTCA Tulsa

Meet our clinical team

A comprehensive team approach

Our doctors are critical to the Lung Cancer Center, but they do not work alone. Rather, they are part of a wider, collaborative team of experts who work in concert—conferring regularly with you and with one another—to design and implement a comprehensive, personalized care plan tailored to your individual needs and treatment goals. Each patient is assigned a dedicated care team of doctors, nurses and supportive care clinicians—led by a medical oncologist and coordinated by a care manager—who are focused on two simultaneous missions: to treat your cancer while helping you manage related side effects so they have less of an impact on your well-being and quality of life.

That’s why, in addition to a pulmonologist, oncologists and other physicians, your Lung Cancer Center care team may also include various supportive care clinicians to help you maintain your strength and stamina while combating side effects like pain, fatigue, nausea and breathing challenges, either from cancer or its treatments. Evidence-informed therapies, such as nutrition counseling, oncology rehabilitation, pain management and mind-body medicine, may be recommended to help you feel and function better—before, during and after treatment. Respiratory therapists trained in smoking cessation techniques also are available if you need help quitting tobacco.

For patients with compromised airways due to their cancer and who are experiencing blockages in their nose, mouth, throat, larynx, trachea or bronchial tubes, we offer additional services tailored to their needs, including advanced diagnostic radiology techniques, speech pathology therapies and pulmonary rehabilitation services.

For patients who are candidates for lung cancer screening, or for those for whom an area of concern cannot be reached via traditional bronchoscopy, robotic bronchoscopy may be an option. This minimally invasive technology allows the Lung Cancer Center team to access areas in the lungs that were previously difficult or impossible to reach for biopsy, genetic testing or treatment. Robotic bronchoscopy may help certain patients avoid a transthoracic needle aspiration, which may increase the risk of complications. Robotic bronchoscopy is also designed to increase the chance of an accurate diagnosis.

In addition, because lung cancer has a high rate of recurrence, the Lung Cancer Center team will follow up with you after treatment is complete, scheduling regular, routine scans, clinical evaluations and chest X-rays to monitor your progress, even after you’ve returned home.

Quality of life

The Lung Cancer Center in Tulsa is committed to the CTCA integrative care model, treating cancer with cutting-edge conventional treatments while supporting patients’ quality of life and well-being with supportive therapies that help them manage cancer-related side effects.

Lung cancer patients often experience side effects like fatigue, appetite loss, pain, nausea or neuropathy. To help you prepare for and address these impacts, your care plan may include supportive therapies, such as pain management, spiritual support, physical therapy and nutrition.

"I think, over the years, my husband Holt and I have learned to appreciate each other more. Having shared these cancer experiences and going through the recoveries has made us stronger and more grateful for the love and compassion we have for each other. And I continue to thank God every day for sending me to CTCA."

Kathleen Houlihan

Kathleen H.

Lung Cancer

MORE ABOUT KATHLEEN

More About KATHLEEN

Our four-day lung nodule diagnosis program

Lung cancer is the second most common non-skin cancer among American men and women, after prostate cancer in men and breast cancer in women. Patients have more treatment options when the disease is diagnosed in its early stages than when it has advanced to later stages. We know the stress and uncertainty that comes with news that an X-ray or CT scan has revealed an abnormal spot on your lung. One of the first things you’ll need to know is if the suspicious mass or nodule is cancerous or benign. Getting a fast, accurate diagnosis is essential to your peace of mind, and your future care, no matter the result. The Lung Cancer Center team of cancer experts understands that time is of the essence and works quickly to provide a diagnosis—in as few as four days—and, if necessary, a treatment plan that meets your needs. Our lung cancer experts have designed a four-day diagnostic program, because they want their patients to get the comprehensive care they need more quickly.

Learn more about our four-day lung nodule diagnosis program

Lung cancer clinical trials

As part of our commitment to provide our patients with innovative, advanced treatment options, we offer a number of clinical trials at the Lung Cancer Center in Tulsa, especially in the use of interventional pulmonology and chemotherapy. Clinical trials offer patients access to drugs and other treatments that may not otherwise be available to them.

Clinical trials Q&A

Are they only available to patients who have exhausted other lung cancer treatment options?

Lung cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer improved outcomes. Other trials are designed for lung cancer patients who have not responded adequately to conventional treatments. Your Lung Cancer Center oncologist will discuss the options and risks, and explain the various protocols involved.

How does CTCA select the trials it offers?

At CTCA, our Lung Cancer Center experts never stop searching for innovative ways to treat lung cancer. Offering carefully selected clinical trials helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our Lung Cancer Center oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.

Who may benefit from lung cancer clinical trials?

The answer is based on a case-by-case analysis of each lung cancer patient. This is a time of rapid scientific advances in lung cancer treatment. New surgical techniques are being developed with a goal of attacking lung tumors while reducing the amount of trauma to healthy tissue. Meanwhile, a new generation of lung cancer therapies is designed to attack tumors that have specific genomic mutations. These new targeted treatments may be more effective and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of lung cancer patients qualifies for participation. The immunotherapy drug nivolumab, for example, is approved for patients with non-squamous non-small cell lung cancer who have already tried platinum-based chemotherapy or EGFR- or ALK-targeted therapies. Genomic tumor testing may determine whether you are a candidate. Other factors—such as your cancer mutations and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific trials.

How do I found out whether a specific clinical trial may benefit me?

Your Lung Center oncologist and care team may recommend a trial depending on your individual needs and treatment goals. For general questions, e-mail the clinical trials team at clinicaltrials@ctca-hope.com or contact an Oncology Information Specialist at 888-841-9129.

Expert care

A team of experts centered on your treatment, caring for the whole person.

Our experts

Finding what works

Offering clinical trials on new and emerging cancer treatment options.

Learn More

Insurance plans

Our hospitals and Outpatient Care Centers accept a wide range of insurance plans.

Verify now